David P. Hochman - Chief Executive Officer and Chairperson, Director at Orchestra BioMed Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer and Chairperson, Director
Issuer Symbol
OBIO on Nasdaq
All Insider Reports
All Insider Reports

David P. Hochman - trading volume in the past year for Orchestra BioMed Holdings, Inc.

Holdings reported by David P. Hochman for Orchestra BioMed Holdings, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.0001 per share ("Common Stock") 1,076,467 $4,467,338 $4.15 12 Feb 2026 Direct
Common Stock 439,482 $1,823,850 $4.15 12 Feb 2026 By the DPH 2008 Trust
Common Stock 3,140 $13,031 $4.15 12 Feb 2026 By the NSH 2008 Family Trust
Common Stock 2,000 $8,300 $4.15 12 Feb 2026 By the Hannah Hochman 2019 Trust
Common Stock 2,000 $8,300 $4.15 12 Feb 2026 By the Judah Herman Hochman 2019 Trust
Common Stock 2,000 $8,300 $4.15 12 Feb 2026 By the Solomon Ascher Hochman 2019 Trust
Stock Option (Right to Buy) 147,500 04 Apr 2025 Direct Common Stock

Transactions reported by David P. Hochman for Orchestra BioMed Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.